Befesa (BFSA) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
17 Jan, 2026Executive summary
Q3 2024 adjusted EBITDA rose 16% year-over-year to €49 million, with nine-month adjusted EBITDA at €152 million, up 11% year-over-year, and operating cash flow up 39% to €118 million.
Steel Dust and Salt Slags segments performed strongly in Europe and the US, offsetting weak secondary aluminium margins and challenging steel and auto sectors.
Strategic focus on deleveraging, with leverage targeted at x3.0 by end-2024 and x2.5 by end-2025, and growth projects prioritized in the US and Germany; China expansion halted.
Zinc price hedging extended to H1 2026 at favorable levels, supporting earnings visibility and incremental EBITDA in 2025.
Net profit for 9M 2024 was €25 million, down 9.3% year-over-year, impacted by higher interest costs and one-time refinancing expenses.
Financial highlights
Q3 2024 revenue was €294 million (+2% YoY); 9M 2024 revenue reached €915 million (+1% YoY).
9M 2024 adjusted EBITDA was €152 million (+11% YoY); Q3 adjusted EBITDA €49 million (+16% YoY); operating cash flow for 9M was €118 million (+39% YoY).
Net leverage at Q3 2024 was x3.36, with net debt at €662 million.
Dividend of €29 million (€0.73/share) paid in Q3 2024.
Cash on hand at period end was €86 million; total liquidity over €166 million including undrawn RCF.
Outlook and guidance
FY2024 adjusted EBITDA is guided at €210–215 million, representing 15–18% year-over-year growth, with Q4 expected to be the strongest quarter.
2025 is expected to deliver strong double-digit EBITDA growth, driven by improved zinc hedging, higher US volumes, and cost reductions.
Leverage targeted to reduce to around x3.0 by year-end 2024 and x2.5 by end of 2025.
Growth capex focused on Palmerton (US) and Bernburg (Germany) projects; China expansion paused.
Latest events from Befesa
- FY2025 delivered robust EBITDA and EPS growth, lower leverage, and a positive 2026 outlook.BFSA
Q4 202512 Mar 2026 - Adjusted EBITDA up 8.8–9% in H1 2024; guidance raised and debt maturities extended.BFSA
Q2 20243 Feb 2026 - Record EBITDA and cash flow in 2024; strong 2025 growth and deleveraging expected.BFSA
Q4 202423 Dec 2025 - Q1 2025 saw double-digit EBITDA and EPS growth, strong cash flow, and lower leverage.BFSA
Q1 202523 Dec 2025 - Adjusted EBITDA up 9% and net profit doubled, with leverage and capex priorities maintained.BFSA
Q2 202516 Nov 2025 - Q3 EBITDA up 26.7–27% YoY, net profit surged, leverage at x2.59, outlook robust.BFSA
Q3 20254 Nov 2025